Clinical Trial Update: Bone Health in Gynecologic Cancers-does FOSAVANCE Help? [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Fosavance for bone health in ovarian cancer has completed. The study explored whether Fosavance provides bone health benefits for women…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Fosavance (alendronic acid; colecalciferol)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED